FDMT vs FLT
4D Molecular Therapeutics Inc (FDMT) versus FLT (FLT) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
FLT (FLT) common stock.
Latest reported FDMT revenue for 2026-06-30 was $6.8M. Net income was -$141.7M. FDMT currently screens at market cap $518.1M.
FLT does not have a complete income-statement cache yet.
FDMT currently screens at market cap $518.1M.
Not investment advice. Open the FDMT and FLT stock pages for the full models.
Not investment advice.